Timothy Barberich - Jun 2, 2023 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role: Director
Signature: /s/ Timothy Barberich
Stock symbol: TCRX
Transactions as of: Jun 2, 2023
Transactions value $: $99,564
Form type: 4
Date filed: 6/6/2023, 07:53 PM
Previous filing: Aug 19, 2022
Next filing: Jun 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCRX	Voting Common Stock	Purchase	$99.6K	+37.9K		$2.63	37.9K	Jun 2, 2023	Direct	F1, F2
holding	TCRX	Voting Common Stock						33.3K	Jun 2, 2023	By Barberich Family Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $2.60 to $2.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2	The Reporting Person's prior reports inadvertently included 33,259 shares of the Issuer's Voting Common Stock held by the Barberich Family Trust as directly owned by the Reporting Person. These shares are held in a trust for the benefit of the Reporting Person's children. The Reporting Person's spouse is the grantor of the trust and retains certain rights to remove and replace the trustee of the trust. The Reporting Person disclaims beneficial ownership of these shares.

Content

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $2.60 to $2.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

The Reporting Person's prior reports inadvertently included 33,259 shares of the Issuer's Voting Common Stock held by the Barberich Family Trust as directly owned by the Reporting Person. These shares are held in a trust for the benefit of the Reporting Person's children. The Reporting Person's spouse is the grantor of the trust and retains certain rights to remove and replace the trustee of the trust. The Reporting Person disclaims beneficial ownership of these shares.